Novo Nordisk stock climbs out of hole on FDA chief’s threat to block Hims and Hers pill
Werte in diesem Artikel
Novo Nordisk shares rallied on Friday in what’s still been a painful week as the Food and Drug Administration may weigh in on the side of the Danish drugmaker in its dispute over a copycat drug.Weiter zum vollständigen Artikel bei MarketWatch
Quelle: MarketWatch